Study Description: This protocol will enroll participants 18 years of age and/or older who have been diagnosed with Hodgkin's lymphoma for which the disease has returned.
Principal Investigator: Locke Bryan
Eligibility Criteria: INCLUSION Diagnosis of Hodgkin Lymphoma Relapsed/Refractory Disease 18 years of age or older One line of prior chemotherapy Adequate organ and bone marrow function within 10 days of registration Subjects must have ability to understand and the willingness to sign informed consent EXCLUSION Patients who have had chemotherapy, radiotherapy, monoclonal antibody (mAb), or targeted small molecule therapy within 4 weeks of study registration Patients currently receiving other investigational agents within 4 weeks of study registration Patients must no have had prior exposure to any immune checkpoint inhibitors Patients must not have known central nervous system (CNS) involvement Patients must not have had prior stem cell transplantation (autologous or allogeneic)
Compensation: No, subjects will not be compensated.
If you don't see specific studies that interest you, please submit your contact information for future studies.